J 2022

Prenylated Flavonoids in Topical Infections and Wound Healing

SYCHROVÁ, Alice, Gabriela ŠKOVRANOVÁ, Marie ČULENOVÁ and Silvia BITTNER FIALOVÁ

Basic information

Original name

Prenylated Flavonoids in Topical Infections and Wound Healing

Authors

SYCHROVÁ, Alice (203 Czech Republic, guarantor, belonging to the institution), Gabriela ŠKOVRANOVÁ (703 Slovakia, belonging to the institution), Marie ČULENOVÁ (203 Czech Republic, belonging to the institution) and Silvia BITTNER FIALOVÁ

Edition

Molecules, Basel, MDPI, 2022, 1420-3049

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30104 Pharmacology and pharmacy

Country of publisher

Switzerland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 4.600

RIV identification code

RIV/00216224:14160/22:00126963

Organization unit

Faculty of Pharmacy

UT WoS

000832513100001

Keywords in English

antibacterial; anti-inflammatory; antioxidant; cytotoxicity; mastitis; MRSA; nanotechnology; prenylated flavonoids; S; aureus; skin; wound healing

Tags

Tags

International impact, Reviewed
Změněno: 19/10/2022 18:00, JUDr. Sabina Krejčiříková

Abstract

V originále

The review presents prenylated flavonoids as potential therapeutic agents for the treatment of topical skin infections and wounds, as they can restore the balance in the wound microenvironment. A thorough two-stage search of scientific papers published between 2000 and 2022 was conducted, with independent assessment of results by two reviewers. The main criteria were an MIC (minimum inhibitory concentration) of up to 32 mu g/mL, a microdilution/macrodilution broth method according to CLSI (Clinical and Laboratory Standards Institute) or EUCAST (European Committee on Antimicrobial Susceptibility Testing), pathogens responsible for skin infections, and additional antioxidant, anti-inflammatory, and low cytotoxic effects. A total of 127 structurally diverse flavonoids showed promising antimicrobial activity against pathogens affecting wound healing, predominantly Staphylococcus aureus strains, but only artocarpin, diplacone, isobavachalcone, licochalcone A, sophoraflavanone G, and xanthohumol showed multiple activity, including antimicrobial, antioxidant, and anti-inflammatory along with low cytotoxicity important for wound healing. Although prenylated flavonoids appear to be promising in wound therapy of humans, and also animals, their activity was measured only in vitro and in vivo. Future studies are, therefore, needed to establish rational dosing according to MIC and MBC (minimum bactericidal concentration) values, test potential toxicity to human cells, measure healing kinetics, and consider formulation in smart drug release systems and/or delivery technologies to increase their bioavailability.